Zimmer Biomet Holdings (LTS:0QQD) Cyclically Adjusted PB Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QQD Zimmer Biomet Holdings Inc LTS:0QQD
74 GF Score
Price CHF77.38
GF Value CHF99.12
! 4 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Zimmer Biomet Holdings  (LTS:0QQD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Zimmer Biomet Holdings Cyclically Adjusted PB Ratio Related Terms


Zimmer Biomet Holdings Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Zimmer Biomet Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings Cyclically Adjusted PB Ratio Chart

Zimmer Biomet Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.24 2.12 1.92 1.59 1.32

Zimmer Biomet Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.34 1.44 1.32 1.30 1.23

LTS:0QQD vs STE, PEN, PODD: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Zimmer Biomet Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zimmer Biomet Holdings Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's Cyclically Adjusted PB Ratio falls into.


LTS:0QQD
74GF Score
Zimmer Biomet Holdings Inc LTS:0QQD
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zimmer Biomet Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Zimmer Biomet Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Zimmer Biomet Holdings's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=52.371/333.9520*333.9520
=52.371

Current CPI (Jun. 2026) = 333.9520.

Zimmer Biomet Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201609 47.374 241.428 65.529
201612 49.135 241.432 67.964
201703 49.347 243.801 67.594
201706 49.238 244.955 67.127
201709 49.693 246.819 67.236
201712 57.173 246.524 77.449
201803 55.949 249.554 74.871
201806 58.617 251.989 77.683
201809 57.988 252.439 76.712
201812 54.804 251.233 72.848
201903 56.348 254.202 74.026
201906 56.219 256.143 73.297
201909 58.210 256.759 75.710
201912 59.090 256.974 76.791
202003 55.102 258.115 71.292
202006 53.526 257.797 69.338
202009 52.397 260.280 67.228
202012 52.184 260.474 66.905
202103 55.525 264.877 70.005
202106 54.711 271.696 67.247
202109 56.139 274.310 68.345
202112 55.792 278.802 66.828
202203 53.279 287.504 61.887
202206 56.094 296.311 63.220
202209 56.805 296.808 63.914
202212 53.579 296.797 60.286
202303 53.935 301.836 59.674
202306 53.349 305.109 58.392
202309 53.850 307.789 58.427
202312 52.496 306.746 57.152
202403 54.422 312.332 58.189
202406 55.578 314.175 59.077
202409 52.524 315.301 55.631
202412 55.841 315.605 59.087
202503 55.343 319.799 57.792
202506 51.467 322.561 53.285
202509 51.238 324.800 52.682
202512 51.763 324.054 53.344
202603 51.625 330.213 52.210
202606 52.371 333.952 52.371

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Zimmer Biomet Holdings (LTS:0QQD) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF77.38 is trading 21.9% below its estimated GF Value™ of CHF99.12.

Key valuation signals for LTS:0QQD:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: CHF99.12 vs. price of CHF77.38 (21.9% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the LTS:0QQD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
74GF Score

Get the complete analysis for LTS:0QQD

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF77.38
Price
CHF99.12
GF Value